摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(2-chloro-ethyl)-2-(2-hydroxy-ethylamino)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-4-one | 66125-32-4

中文名称
——
中文别名
——
英文名称
3-(2-chloro-ethyl)-2-(2-hydroxy-ethylamino)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-4-one
英文别名
3-(2-chloro-ethyl)-2-(2-hydroxy-ethylamino)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-4-one
3-(2-chloro-ethyl)-2-(2-hydroxy-ethylamino)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-4-one化学式
CAS
66125-32-4
化学式
C7H14ClN2O4P
mdl
——
分子量
256.626
InChiKey
NPLQTFPNUFVZAU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.16
  • 重原子数:
    15.0
  • 可旋转键数:
    5.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    78.87
  • 氢给体数:
    2.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    3-(2-chloro-ethyl)-2-(2-hydroxy-ethylamino)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-4-onesodium hydroxide 作用下, 以 氯仿 为溶剂, 生成 N-(2-chloro-ethyl)-3-(2-oxo-2λ5-[1,3,2]oxazaphospholidin-2-yloxy)-propionamide
    参考文献:
    名称:
    Studies on the urinary metabolites of isophosphamide and its activated species in rabbits.
    摘要:
    对兔子尿液中异磷酰胺、4-羟基异磷酰胺和 4-羟基异磷酰胺(包括 C4 氧化衍生物的立体异构体)代谢产物的研究表明,它们的代谢行为与环磷酰胺不同。兔子服用异磷酰胺后,除了排出大量未改变的异磷酰胺外,尿液中还会排出羧基异磷酰胺和两种 N-脱氯乙基代谢物,而 4-羟基异磷酰胺则主要代谢为羧基异磷酰胺。就 4-羟基异磷酰胺而言,羧基异磷酰胺是排出体外的主要代谢物,但除了少量的 4-酮异磷酰胺外,还排出了相当数量的新代谢物,这种新代谢物可能是由 4-酮异磷酰胺通过迄今未知的途径产生的。这种新的代谢物的形成机制是根据所建议的中间体向代谢物的化学转化而提出的。研究发现,C4-氧化异磷酰胺的 PHosphorus 构型对其代谢没有明显影响。有人认为,本研究的结果可以解释异磷酰胺及其活化前衍生物之间以及异磷酰胺与环磷酰胺之间体内抗肿瘤活性的巨大差异。
    DOI:
    10.1248/cpb.25.2900
  • 作为产物:
    描述:
    N-(2-benzyloxy-ethyl)-N'-(2-chloro-ethyl)-phosphorodiamidic acid but-3-enyl ester 在 palladium on activated charcoal 氢气 作用下, 以 甲醇 为溶剂, 反应 7.0h, 生成 3-(2-chloro-ethyl)-2-(2-hydroxy-ethylamino)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-4-one
    参考文献:
    名称:
    Studies on the urinary metabolites of isophosphamide and its activated species in rabbits.
    摘要:
    对兔子尿液中异磷酰胺、4-羟基异磷酰胺和 4-羟基异磷酰胺(包括 C4 氧化衍生物的立体异构体)代谢产物的研究表明,它们的代谢行为与环磷酰胺不同。兔子服用异磷酰胺后,除了排出大量未改变的异磷酰胺外,尿液中还会排出羧基异磷酰胺和两种 N-脱氯乙基代谢物,而 4-羟基异磷酰胺则主要代谢为羧基异磷酰胺。就 4-羟基异磷酰胺而言,羧基异磷酰胺是排出体外的主要代谢物,但除了少量的 4-酮异磷酰胺外,还排出了相当数量的新代谢物,这种新代谢物可能是由 4-酮异磷酰胺通过迄今未知的途径产生的。这种新的代谢物的形成机制是根据所建议的中间体向代谢物的化学转化而提出的。研究发现,C4-氧化异磷酰胺的 PHosphorus 构型对其代谢没有明显影响。有人认为,本研究的结果可以解释异磷酰胺及其活化前衍生物之间以及异磷酰胺与环磷酰胺之间体内抗肿瘤活性的巨大差异。
    DOI:
    10.1248/cpb.25.2900
点击查看最新优质反应信息

文献信息

  • Studies on the urinary metabolites of isophosphamide and its activated species in rabbits.
    作者:AKIRA TAKAMIZAWA、TSUYOSHI IWATA、SAICHI MATSUMOTO
    DOI:10.1248/cpb.25.2900
    日期:——
    Investigations on the urinary metabolites of isophosphamide, 4-hydroxyisophosphamide and 4-hydroxyisophosphamide including stereoisomers of the C4-oxidized derivatives in rabbits revealed that their metabolic behaviors were different from each other and also form those of cyclophosphamide. Administration of isophosphamide to rabbits resulted in the urinary excretion of carboxyisophosphamide and two N-dechloroethylated metabolites besides considerable amount of unchanged isophosphamide, while 4-hydroxyisophosphamide was metabolized principally into carboxyisophosphamide. In the case of 4-hydroxyisophosphamide, carboxyisophosphamide was excreted as a major metabolite, but considerable amount of a new metabolite which might be produced from 4-ketoisophosphamide via a hitherto unknown pathway was also excreted besides small amount of 4-ketoisophosphamide. Mechanism of the formation of this new metabolite was proposed based on the chemical conversion of a suggested intermediate into the metabolite. PHosphorus configuration of the C4-oxidized isophosphamides was found to have no significant effect upon their metabolism. It was suggested that the results of the present studies could account for the great differences in in vivo antitumor activities between isophosphamide and its pre-activated derivatives and also between isophosphamide and cyclophosphamide.
    对兔子尿液中异磷酰胺、4-羟基异磷酰胺和 4-羟基异磷酰胺(包括 C4 氧化衍生物的立体异构体)代谢产物的研究表明,它们的代谢行为与环磷酰胺不同。兔子服用异磷酰胺后,除了排出大量未改变的异磷酰胺外,尿液中还会排出羧基异磷酰胺和两种 N-脱氯乙基代谢物,而 4-羟基异磷酰胺则主要代谢为羧基异磷酰胺。就 4-羟基异磷酰胺而言,羧基异磷酰胺是排出体外的主要代谢物,但除了少量的 4-酮异磷酰胺外,还排出了相当数量的新代谢物,这种新代谢物可能是由 4-酮异磷酰胺通过迄今未知的途径产生的。这种新的代谢物的形成机制是根据所建议的中间体向代谢物的化学转化而提出的。研究发现,C4-氧化异磷酰胺的 PHosphorus 构型对其代谢没有明显影响。有人认为,本研究的结果可以解释异磷酰胺及其活化前衍生物之间以及异磷酰胺与环磷酰胺之间体内抗肿瘤活性的巨大差异。
查看更多

同类化合物

曲磷胺 曲磷胺 异环磷酰胺杂质F 异环磷酰胺 [(2-羟基-2-氧代-1,4,2-氧氮杂磷杂环己烷-4-基)甲基]膦酸 4-过氧化氢异环磷酰胺 4-氧代异环磷酰胺 4-乙基-7-甲基-7-氮杂-2,6-二氧杂-1-磷杂双环[2.2.2]辛烷1-硫化物 2’-氧代异环磷酰胺 2-[2-氯乙基-[3-(2-氯乙基)-2-氧代-1-氧杂-3-氮杂-2-磷杂环己-2-基]氨基]乙基甲烷磺酸酯 2,3,4,6,7,8-六氢-[1,3,2]氧氮杂膦咛并[2,3-b][1,3,2]氧氮杂膦咛 (2-氯-乙基)-[(R)-3-(2-氯-乙基)-2-氧代-2lambda5-[1,3,2]氧氮杂磷杂环己烷-2-基]-胺 (2R*,4aS*,8aR*)-1-methyl-2-phenyl-1,4,4a,5,6,7,8,8a-octahydro-2H-3,1,2-benzoxazaphosphinine 2-oxide (2S*,4aS*,8aR*)-2-phenyl-1,4,4a,5,6,7,8,8a-octahydro-2H-3,1,2-benzoxazaphosphinine 2-oxide (2R*,4aS*,8aS*)-1-methyl-2-phenyl-1,4,4a,5,6,7,8,8a-octahydro-2H-3,1,2-benzoxazaphosphinine 2-oxide (2S*,4aS*,8aS*)-2-phenyl-1,4,4a,5,6,7,8,8a-octahydro-2H-3,1,2-benzoxazaphosphinine 2-oxide (S,S)-2-oxo-2-propionyl-1,3,2-oxaphosphorinane 2-(Dimethylamino)-3-phenyl-1,3,2-oxazaphosphorinane 2-(1,1,1,3,3,3-Hexafluoroisopropoxy)-3,5,5-trimethyl-1,3,2-oxazaphosphorinane cis-2-(1,1,1,3,3,3-Hexafluoroisopropoxy)-3-methyl-5-tert-butyl-1,3,2-oxazaphosphorinane 2-(1,1,1,3,3,3-Hexafluoroisopropoxy)-3-methyl-1,3,2-oxazaphosphorinane 2-(1,1,1,3,3,3-Hexafluoroisopropoxy)-3-phenyl-1,3,2-oxazaphosphorinane 3,3,5,5-tetramethyl-2-oxido-2-oxo-1,4,2-oxaazaphosphorinane 2-(2-chloroethylamino)-3-(1-methyl-2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide 4-ethyl-2-hydroxy-2-oxo-tetrahydro-4H-1,4,2-oxazaphosphorine geranyloxyifosfamide 4-methoxy-ifosfamide (2-chloroethyl)-[3-(2-chloroethyl)-2-oxo-4-pentyloxy-2λ5-[1,3,2]oxazaphosphinan-2-yl]amine 3-ethyl-2-hydroxy-2-oxo-1,4,2-oxazaphosphorinane Methyl-[3-(3-methyl-[1,3,2]oxazaphosphinan-2-yloxy)-propyl]-amine 2-Oxo-3-(propan-2-yl)-1,3,2-oxazaphosphinan-2-ium 3-(2-Chloroethyl)-2-(2-chloroethyl)amino-4-hydroxytetrahydro-2H-1,3,2-oxazaphosphorine 3-(2-Chloroethyl)-2-(1-ethyl-2-mesyloxyethylamino)-tetrahydro-2H-1,3,2-oxazaphosphorin-2-oxide 2H-1,3,2-Oxazaphosphorine, 2-fluorotetrahydro-3,5-dimethyl-, 2-oxide 2H-1,3,2-Oxazaphosphorine, 2-fluorotetrahydro-3,4-dimethyl-, 2-oxide (3-Isopropyl-2-oxo-2λ5-[1,3,2]oxazaphosphinan-2-yl)-acetic acid methyl ester cis-2-mesityl-2-oxo-3-phenyl-5-tert-butyl-1,3,2λ5-oxazaphosphorinane trans-2-mesityl-2-oxo-3-phenyl-5-tert-butyl-1,3,2λ5-oxazaphosphorinane (2S,6S)-2-Benzyl-3-(1,1-diethyl-propyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide (2R,6S)-2-Benzyl-3-(1,1-diethyl-propyl)-6-methyl-[1,3,2]oxazaphosphinane 2-oxide (2S,6S)-2-((E)-2-Allyloxy-but-2-enyl)-3-tert-butyl-6-methyl-[1,3,2]oxazaphosphinane 2-oxide (2R,6S)-2-((E)-2-Allyloxy-but-2-enyl)-3-tert-butyl-6-methyl-[1,3,2]oxazaphosphinane 2-oxide (S)-(2l,6l)-2-(methoxymethyl)-6-methyl-3-(1-methylethyl)-1,3,2-oxazaphosphorinane 2-sulfide (S)-1-((2S,6S)-3-tert-Butyl-6-methyl-2-oxo-2λ5-[1,3,2]oxazaphosphinan-2-yl)-3-methyl-hex-5-en-2-one 2-methoxy-1,3,2-oxazaphosphinane 3-(2-Chloroethyl-2-<(2-chloroethyl)-(3-mesyloxytrimethylen)-amino>-tetrahydro-2H-1,3,2-oxazaphosphorin-2-oxide 2-chloro-3-[(S)-α-methylbenzyl]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide (S)-(2u,6l)-3-(1,1-Diethylpropyl)-6-methyl-2-(2-propenyl)-1,3,2-oxazaphosphorinane 2-oxide 3-(2-chloro-ethyl)-2-(2-hydroxy-ethylamino)-2-oxo-2λ5-[1,3,2]oxazaphosphinan-4-one isopropyl-[3-(3-isopropyl-[1,3,2]oxazaphosphinan-2-yloxy)-propyl]-amine